Dr. Breanne Everett founded Orpyx® to help address the world’s growing epidemic of diabetes and its associated complications, most notably, diabetic peripheral neuropathy. The diabetic foot ulcer is one of the most devastating complications of diabetes, occurring in upwards of 15% of all diabetic patients and preceding 84% of all lower leg amputations. In response, Dr. Everett created SurroSense Rx™, a state of the art pressure-sensing insole to collect pressure data from the foot to alert the user when damage is being done so that patient behavior can be modified and devastating complications may be avoided.

Creating the app

Little Green Software created the SurroSense Rx ™ app for iOS and Android that connects wirelessly to the SurroSense Rx™ insoles and runs quietly in the background to monitor pressure levels.

The app features an easy to use, step-by-step set up guide that introduces the user to the product, explains what to expect, then directs the user to the set up screen where they are guided to enter information. A more general “Help” section was also created as part of the app, including a guide about foot care.


The product is currently in clinical trials at the University of Arizona, after passing exhaustive in-house testing and pre-clinical testing at Orpyx®. Little Green Software will continue working with Orpyx® throughout these trials, to ensure that user feedback is incorporated into the application by the time it enters the market in Canada and the US.

Orpyx has already received a number of industry awards and honors, as well as media and investor recognition, for this life-changing product.